Allergy/Immunology
RSSArticles
-
Reduce the Risk of Autoimmune Disease with Vitamin D, n-3 Fatty Acid Supplements
A randomized, controlled trial that included older adults showed vitamin D3 2,000 units daily or n-3 fatty acids 1,000 mg daily over five years reduced the incidence of autoimmune diseases 25% to 30%.
-
Fluvoxamine Reduces the Risk for Hospitalization from COVID-19
Researchers found fluvoxamine (100 mg twice a day for 10 days) lowered the risk for hospitalization among high-risk outpatients diagnosed with COVID-19.
-
Researchers: Emergency Providers Missing Chances to Avert Future Opioid Disasters
Investigators express concern about prescribing rates for medication-assisted treatment after ED visits for opioid overdoses recorded between late 2019 and early 2021.
-
Positive STI Test Results Not Always Shared with Study Participants
Investigators should develop a plan to return test results to participants, and document their actions in protocols and manuscripts. IRBs should require researchers to include these details in their proposals.
-
Regulators Sign Off on COVID-19 Vaccine ‘Mix and Match’
Federal agencies expand, clarify guidance on booster shots.
-
CDC Pledges Massive Investment in Infection Control and Prevention
Outlay to boost current battles against COVID-19 pandemic and prepare the healthcare industry to protect against future threats.
-
FDA Gives Full Approval to Pfizer’s COVID-19 Vaccine
A significant milestone in the ongoing battle against the pandemic.
-
A Probiotic May Cause Sepsis and Death
Saccharomyces boulardii is a probiotic yeast that may cause fungemia and other fungal infections. -
AstraZeneca Reports 79% Efficacy for U.S. COVID-19 Vaccine Candidate
But NIH raises questions the about data.
-
HHS Releases Latest Iteration of Antibiotic Resistance Action Plan
The five-point strategy crafted in previous years remains the same, but the tactics have improved to help execute the goals. The new plan includes details about stronger and more evidence-based activities that have reduced antibiotic resistance that public health officials can lean on to drive progress.